Rani Therapeutics Holdings, Inc.
RANI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001856725
In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Rani Therapeutics Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 2 filings
- 2 insiders, $50.0K in total
- Open-market sells
- 2 filings
- 2 insiders, $11.6K in total
- Insiders trading
- 3
- Net value
- +$38.4K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Rani Therapeutics Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Gilson Michelle | Director | – | Aug 4, 2026 | 1 |
| Imran Mir A | Director, 10% Owner | 2,119,334 | Jul 23, 2026 | 3 |
| Javadi Alireza | Chief Technical Officer | 9,380 | Jul 21, 2026 | 2 |
| Imran Talat | Chief Executive Officer | 469,736 | Jul 21, 2026 | 3 |
| Maestas Nicholas | Chief Financial Officer | – | Jul 21, 2026 | 1 |
| McKinley Kate | Chief Business Officer | 17,960 | Jun 5, 2026 | 1 |
| Butel Jean Luc | Director | 50,500 | Jun 1, 2026 | 1 |
| Ausiello Dennis A | Director | – | Jun 1, 2026 | 1 |
| Bassan Abraham | Director | – | Jun 1, 2026 | 2 |
| Rometty Lisa Ann | Director | – | Jun 1, 2026 | 1 |
| Bailey Vasudev Jaiprakash | Director | – | Jun 1, 2026 | 2 |
| South Cone Investments Limited Partnership | 10% Owner | 2,379,194Indirect | Oct 22, 2025 | 1 |
| Nanavaty Maulik | Director | 500 | May 30, 2025 | 0 |
| Farquharson Andrew | Director | 72,818Indirect | May 30, 2025 | 0 |
| Sanford Svai S | Chief Financial Officer | 258,597 | May 23, 2025 | 0 |
| Hashim Mir | Chief Scientific Officer | 273,265 | May 23, 2025 | 0 |
| Debuono Laureen | Director | – | Dec 17, 2024 | 0 |
| South Lake One LLC | 10% Owner | 8,302,194Indirect | Oct 17, 2024 | 0 |
| Groen Eric | General Counsel | 163,216 | Mar 22, 2024 | 0 |
| Quiroga Cortes Isidoro Alfonso | 10% Owner | 8,400Indirect | Dec 8, 2023 | 0 |
| Aequanimitas Limited Partnership | 10% Owner | 8,400Indirect | Dec 8, 2023 | 0 |
| Baranowski Lyn | Director | – | May 27, 2022 | 0 |
| InCube Labs, L.L.C. | 10% Owner | 13,923 | Feb 7, 2022 | 0 |
| Quiroga Moreno Isidoro | 10% Owner | 11,731,654Indirect | Aug 3, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 7, 2023 (view filing) | Dec 6 | 1 day | Imran TalatChief Executive Officer | PPurchaseClass A Common Stock | +10.0K | $2.27 | +$22.7K | +2.1%484.5K after | |
| Dec 8, 2023 (view filing)4:27 PM ET | Nov 24 | 14 daysLate | South Lake One LLC and 1 other10% Owner | PPurchaseClass A Common Stock | +5.27M | $2.01 | +$10.6M | +76.7%12.1M after | |
| Dec 8, 2023 (view filing)4:29 PM ET | Nov 24 | 14 daysLate | Quiroga Cortes Isidoro Alfonso and 1 other10% Owner | SSaleClass A Common Stock | −5.27M | $2.01 | −$10.6M | −99.8%8.40K after | |
| Oct 17, 2024 (view filing)4:30 PM ET | Oct 15 | 2 days | South Lake One LLC and 1 other10% Owner | SSaleClass A Common Stock | −3.83M | $2.65 | −$10.1M | −31.6%8.30M after | 2 lots |
| Dec 10, 2024 (view filing) | Dec 9 | 1 day | Imran TalatChief Executive Officer | PPurchaseClass A Common Stock | +10.3K | $1.94 | +$20.0K | +2.1%494.8K after | |
| Dec 16, 2024 (view filing) | Dec 13 | 3 days | McKinley KateChief Business Officer | PPurchaseClass A Common Stock | +18.0K | $1.67 | +$30.0K | New position18.0K after | |
| Oct 22, 2025 (view filing) | Oct 20-21 | 2 days | South Cone Investments Limited Partnership10% Owner | SSaleClass A Common Stock | −5.92M | $2.65 | −$15.7M | −71.3%2.38M after | 2 lots |
| Oct 27, 2025 (view filing) | Oct 23 | 4 days | Imran Mir ADirector, 10% Owner | PPurchaseClass A Common Stock | +2.08M | $0.61 | +$1.27M | New position2.08M after | |
| Oct 27, 2025 (view filing) | Oct 23 | 4 days | Imran Mir ADirector, 10% Owner | PPurchaseClass A Common Stock | +2.08M | $0.00 | $0 | –2.08M after | Derivative |
| Jul 21, 2026 (view filing)6:25 PM ET | Dec 27, 2024 | 571 daysLate | Imran TalatChief Executive Officer | SSaleClass A Common Stock | −8.01K | $1.41 | −$11.3K | −1.6%486.7K after | |
| Jul 21, 2026 (view filing)6:29 PM ET | Jul 17 | 4 days | Imran TalatChief Executive Officer | PPurchaseClass A Common Stock | +35.0K | $0.7198 | +$25.2K | +8.1%469.7K after | |
| Jul 21, 2026 (view filing)7:24 PM ET | Mar 27 | 116 daysLate | Javadi AlirezaChief Technical Officer | SSaleClass A Common Stock | −386 | $0.78 | −$301.08 | −3.8%9.69K after | |
| Jul 23, 2026 (view filing)4:10 PM ET | Jul 21 | 2 days | Imran Mir ADirector, 10% Owner | PPurchaseClass A Common Stock | +36.0K | $0.69 | +$24.8K | +1.7%2.12M after |